PUT/EVOTEC/15/0.1/20.12.24 Share Price

Warrant

DE000GZ6DTK2

Real-time BOERSE MUENCHEN 05:57:21 20/06/2024 pm IST
0.681 EUR -11.21% Intraday chart for PUT/EVOTEC/15/0.1/20.12.24
Current month+16.21%
1 month+42.30%
Date Price Change
20/24/20 0.681 -11.21%
19/24/19 0.767 +1.05%
18/24/18 0.759 +0.40%
17/24/17 0.756 +11.67%
14/24/14 0.677 +2.73%

Real-time BOERSE MUENCHEN

Last update June 20, 2024 at 05:57 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying EVOTEC SE
Issuer Goldman Sachs
WKN GZ6DTK
ISINDE000GZ6DTK2
Date issued 30/12/2022
Strike 15
Maturity 20/12/2024 (183 Days)
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.767
Lowest since issue 0.082
Delta-0.77x
Omega 0.9700
Premium2.37x
Gearing1.25x
Moneyness 1.775
Difference Strike 6.56
Difference Strike %+43.73%
Spread 0.01
Spread %1.47%
Theoretical value 0.6780
Implied Volatility 78.79 %
Total Loss Probability 10.17 %
Intrinsic value 0.6535
Present value 0.0245
Break even 8.220 €
Theta-0x
Vega0x
Rho-0.01x

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
7.335 EUR
Average target price
20.79 EUR
Spread / Average Target
+183.44%
Consensus